NO973103D0 - Fremgangsmåte for inhibering av veksthormoneffekter - Google Patents

Fremgangsmåte for inhibering av veksthormoneffekter

Info

Publication number
NO973103D0
NO973103D0 NO973103A NO973103A NO973103D0 NO 973103 D0 NO973103 D0 NO 973103D0 NO 973103 A NO973103 A NO 973103A NO 973103 A NO973103 A NO 973103A NO 973103 D0 NO973103 D0 NO 973103D0
Authority
NO
Norway
Prior art keywords
growth hormone
inhibiting growth
hormone effects
effects
inhibiting
Prior art date
Application number
NO973103A
Other languages
English (en)
Other versions
NO973103L (no
Inventor
Timothy Alan Grese
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO973103L publication Critical patent/NO973103L/no
Publication of NO973103D0 publication Critical patent/NO973103D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
NO973103A 1995-01-12 1997-07-03 Fremgangsmåte for inhibering av veksthormoneffekter NO973103D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/372,753 US5494929A (en) 1995-01-12 1995-01-12 Methods of inhibiting growth hormone effects
PCT/US1995/016809 WO1996021441A1 (en) 1995-01-12 1995-12-22 Methods of inhibiting growth hormone effects

Publications (2)

Publication Number Publication Date
NO973103L NO973103L (no) 1997-07-03
NO973103D0 true NO973103D0 (no) 1997-07-03

Family

ID=23469503

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973103A NO973103D0 (no) 1995-01-12 1997-07-03 Fremgangsmåte for inhibering av veksthormoneffekter

Country Status (12)

Country Link
US (1) US5494929A (no)
EP (1) EP0796095A4 (no)
JP (1) JPH10512260A (no)
KR (1) KR19980701329A (no)
CN (1) CN1177295A (no)
AU (1) AU701267B2 (no)
CA (1) CA2209891A1 (no)
CZ (1) CZ217497A3 (no)
FI (1) FI972968A (no)
HU (1) HUT77381A (no)
NO (1) NO973103D0 (no)
WO (1) WO1996021441A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458811B1 (en) * 1996-03-26 2002-10-01 Eli Lilly And Company Benzothiophenes formulations containing same and methods
EA001257B1 (ru) * 1996-03-26 2000-12-25 Эли Лилли Энд Компани Бензотиофены, содержащие их фармацевтические композиции и способы лечения патологических состояний с их использованием
GB2324726A (en) * 1997-05-01 1998-11-04 Merck & Co Inc Combination Therapy for the Treatment of Osteoporosis
US5990129A (en) * 1997-09-23 1999-11-23 Eli Lilly And Company Methods for regulating trkA expression

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
US5445941A (en) * 1993-06-21 1995-08-29 Eli Lilly And Company Method for screening anti-osteoporosis agents
US5441966A (en) * 1993-12-21 1995-08-15 Eli Lilly And Company Methods of inhibiting Turner's syndrome
US6562862B1 (en) * 1994-10-20 2003-05-13 Eli Lilly And Company Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y

Also Published As

Publication number Publication date
AU4659196A (en) 1996-07-31
CA2209891A1 (en) 1996-07-18
MX9705215A (es) 1997-10-31
FI972968A0 (fi) 1997-07-11
US5494929A (en) 1996-02-27
NO973103L (no) 1997-07-03
FI972968A (fi) 1997-07-11
CN1177295A (zh) 1998-03-25
EP0796095A4 (en) 1999-01-07
AU701267B2 (en) 1999-01-21
WO1996021441A1 (en) 1996-07-18
HUT77381A (hu) 1998-04-28
EP0796095A1 (en) 1997-09-24
JPH10512260A (ja) 1998-11-24
KR19980701329A (ko) 1998-05-15
CZ217497A3 (cs) 1998-01-14

Similar Documents

Publication Publication Date Title
FI923421A0 (fi) Menetelmä siementen päällystämiseksi
GB2297049B (en) Method for film formation
KR970001615A (ko) 실리콘 결정 성장 제어방법
NO973009D0 (no) Fremgangsmåte for å inhibere kathepsin-k
NO982991D0 (no) Veksthormon-sekretagoguer
DE69534965D1 (de) Abscheidungsverfahren
NO975159D0 (no) Fremgangsmåte for kontroll av biologisk nedbrytning
KR970001365A (ko) 알킬하이드로겐클로로실란의 제조방법
DE69620104D1 (de) Farbkorrekturverfahren
NO974169D0 (no) Fremgangsmåte for tetra-azacykloalkan-fremstilling
GB2297562B (en) Knitting method
EE03161B1 (et) Meetod idandatava seemnematerjali töötlemiseks
HUP9801631A3 (en) Method for attracting of insects
GB2297050B (en) Method for film formation
ZA965422B (en) Method for controlling insects
NO965497L (no) Fremgangsmåte for kontrollert fiksering av avleiringsinhibitor i en underjordisk formasjon
GB2308522B (en) Redialling method
NO973103D0 (no) Fremgangsmåte for inhibering av veksthormoneffekter
IL134390A0 (en) Method for fumigating soil
IS4285A (is) Aðferð við að hindra útfellingu
FI973235A0 (fi) Menetelmä IL-6:n vaikutusten inhiboimiseksi
KR970006291A (ko) 치환된 아미노카보닐트리아졸리논의 제조방법
KR970001321A (ko) 2-피롤리돈의 제조 방법
AP9701121A0 (en) Method for prearing streptogramines
IL117635A0 (en) Method for controlling acridians